Investing news
Latest investment headlines, research & analysis
Should I sell Viatris shares after Q2 results failed to meet revenue expectations?
- Viatris reported Q2 results on Monday
- Total revenue has decreased by 10% Y/Y
- Viatris lowered the revenue outlook for the 2022 fiscal year
August 14, 2022
Sonos stock plunges after weak demand encourage forecast cut
August 13, 2022
This beaten down Cathie Wood stock is a ‘buy’: DA Davidson
August 12, 2022
Trending news
Market analysis
Lloyds share price is about 65% undervalued. Should you buy?
August 12, 2022
Rolls-Royce share price is 21% undervalued. Is it a good buy?
August 12, 2022
Stock, index & exchanges data
Major indices
| Value | Change | % Change | ||
|---|---|---|---|---|
| ^BVSP | 112764.26 | +3,046.32 | +2.78% | |
| IBOVESPA | ||||
| ^N225 | 28546.98 | +727.65 | +2.62% | |
| Nikkei 225 | ||||
| ^IXIC | 13047.186 | +267.27 | +2.09% | |
| NASDAQ Composite | ||||
| ^RUT | 2016.6161 | +41.36 | +2.09% | |
| Russell 2000 | ||||
| ^GSPC | 4280.15 | +72.88 | +1.73% | |
| S&P 500 | ||||
| ^XAX | 4219.6396 | +54.88 | +1.32% | |
| NYSE AMEX COMPOSITE INDEX | ||||
| ^NYA | 15804.385 | +201.46 | +1.29% | |
| NYSE COMPOSITE (DJ) | ||||
| ^DJI | 33761.05 | +424.38 | +1.27% | |
| Dow Jones Industrial Average | ||||
| ^GSPTSE | 20179.81 | +187.93 | +0.94% | |
| S&P/TSX Composite index | ||||
| ^MXX | 48853.37 | +392.82 | +0.81% | |
| IPC MEXICO | ||||
Top fallers
| Value | Change | % Change | ||
|---|---|---|---|---|
| NYSE:OLO | 8.26 | -4.73 | -36.41% | |
| Olo Inc - Class A | ||||
| NASDAQ:FWAA | 3.82 | -1.79 | -31.91% | |
| SmartRent Inc - Class A | ||||
| NASDAQ:TOP | 13.84 | -5.41 | -28.10% | |
| TOP Financial Group Limited | ||||
| NYSE:VPCC | 0.6671 | -0.19 | -22.32% | |
| Dave Inc - Class A | ||||
| OTCMKTS:WETG | 11.23 | -3.16 | -21.96% | |
| WeTrade Group | ||||
| NASDAQ:APYX | 8.25 | -2.03 | -19.75% | |
| Apyx Medical Corp | ||||
| NASDAQ:CERT | 17.56 | -2.63 | -13.03% | |
| Certara Inc | ||||
| NYSE:LNFA | 7.19 | -1.07 | -12.95% | |
| ZeroFox Holdings Inc | ||||
| NASDAQ:GCAC | 1.5 | -0.22 | -12.79% | |
| Cepton Inc | ||||
| NASDAQ:BCAB | 6.99 | -0.96 | -12.07% | |
| BioAtla Inc | ||||
Top risers
| Value | Change | % Change | ||
|---|---|---|---|---|
| NYSE:NGAB | 1.07 | +0.49 | +84.80% | |
| Embark Technology Inc | ||||
| NASDAQ:RANI | 11.32 | +3.09 | +37.55% | |
| Rani Therapeutics Holdings Inc Class A | ||||
| TSE:NVEI | 48.21 | +12.87 | +36.42% | |
| Nuvei Corporation (Sub Voting) | ||||
| NASDAQ:RAAC | 2.87 | +0.69 | +31.65% | |
| Berkshire Grey Inc - Class A | ||||
| NYSE:SPNV | 2.19 | +0.50 | +29.59% | |
| Offerpad Solutions Inc - Class A | ||||
| NASDAQ:LQDA | 7.3 | +1.59 | +27.85% | |
| Liquidia Corp | ||||
| NYSE:ADCT | 10.3 | +2.18 | +26.85% | |
| Adc Therapeutics SA | ||||
| NASDAQ:AIRS | 11.2 | +2.32 | +26.13% | |
| Airsculpt Technologies Inc | ||||
| NASDAQ:ALT | 17.36 | +3.59 | +26.07% | |
| Altimmune Inc | ||||
| NASDAQ:ATRA | 5.84 | +1.19 | +25.59% | |
| Atara Biotherapeutics Inc | ||||
